Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122743 · ClinicalTrials.gov registry record
Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 61
- Enrollment target
NCT03122743: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03122743 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122743 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
This pilot research trial studies the collection of serum samples in studying emotional stress in patients with prostate cancer. Studying serum samples from patients with prostate cancer in the laboratory may help doctors determine if levels of epinephrine and cortisol, substances the body makes when stressed, rise or fall with how patients are feeling and/or if those levels are related to clinical information related to prostate cancer.
Primary Outcome
Will calculate the patient's stress levels at each of the 5 visits using a validated distress thermometer
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2020-09-24 |
What the finished NCT03122743 record still lists
NCT03122743 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT03122743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03122743 about?
NCT03122743 is a clinical study titled "Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer". This pilot research trial studies the collection of serum samples in studying emotional stress in patients with prostate cancer. Studying serum samples from patients with prostate cancer in the laboratory may help doctors determine if levels of epinephrine and cortisol, substances the body makes whe...
What is the current status of trial NCT03122743?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2017-02-22. Estimated completion is 2020-09-24.
What interventions are being tested in trial NCT03122743?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT03122743?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI